These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5235751)

  • 41. [Therapeutic experience in the use of erythromycin stearate in chronic intestinal amebiasis].
    de Oliveira CA
    Hospital (Rio J); 1969 Jul; 76(1):175-8. PubMed ID: 5307522
    [No Abstract]   [Full Text] [Related]  

  • 42. [Amebicidal activity of erythromycin stearate: clinicotherapeutic aspects].
    Waks J
    Prensa Med Argent; 1965 Apr; 52(13):781-2. PubMed ID: 5828419
    [No Abstract]   [Full Text] [Related]  

  • 43. Preparation and evaluation of a new erythromycin derivative -- erythromycin taurate.
    Manna PK; Kumaran V; Mohanta GP; Manavalan R
    Acta Pharm; 2004 Sep; 54(3):231-42. PubMed ID: 15610619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of intestinal amebiasis with erythromycin stearate. Parastitic study of fecal material].
    Meeroff M
    Bol Chil Parasitol; 1968; 23(1):45-7. PubMed ID: 5705124
    [No Abstract]   [Full Text] [Related]  

  • 45. [Erythromycin stearate in the treatment of common dental infections].
    Haydée Marchesi M
    Trib Odontol (B Aires); 1969; 53(4):110 passim. PubMed ID: 5258682
    [No Abstract]   [Full Text] [Related]  

  • 46. [Specific action of erythromycin stearate as an amebicide].
    Vendemiatti E
    Rev Bras Med; 1969 Dec; 26(12):749-53. PubMed ID: 5386029
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinico-paracytological and therapeutic study with a new preparation of erythromycin stearate of controlled release (A-16535) in intestinal amebiasis].
    Segal J
    Rev Bras Med; 1967 Aug; 24(8):626-32. PubMed ID: 5603001
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of chronic intestinal amebiasis using non-absorbent erythromycin stearate (case study)].
    Pádua Mde A
    Rev Bras Med; 1969 Sep; 26(9):549-52. PubMed ID: 5381894
    [No Abstract]   [Full Text] [Related]  

  • 49. [The choice of a local treatment in stomatologic practice. Therapeutic experiments].
    Bouchouchi ; Siau
    Inf Dent; 1968 May; 50(20):2103-8. PubMed ID: 5244490
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of an erythromycin stearate preparation, of regulated intestinal release in the treatment of intestinal amebiasis].
    Amato Neto V; Wanderley RA
    Hospital (Rio J); 1968 Feb; 73(2):583-9. PubMed ID: 5311770
    [No Abstract]   [Full Text] [Related]  

  • 51. A review of commonly prescribed oral antibiotics in general dentistry.
    Karlowsky J; Ferguson J; Zhanel G
    J Can Dent Assoc; 1993 Mar; 59(3):292-4, 297-300. PubMed ID: 8453530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinico-parasitological evaluation of an anti-ameba therapeutic activity of a new non-absorbable erythromycin stearate preparation].
    Alterio DL
    Hospital (Rio J); 1968 Apr; 73(4):1207-13. PubMed ID: 5307504
    [No Abstract]   [Full Text] [Related]  

  • 53. Pediatric erythromycins: a comparison of the properties of erythromycins A and B 2'-ethyl succinates.
    Hassanzadeh A; Gorry PA; Morris GA; Barber J
    J Med Chem; 2006 Oct; 49(21):6334-42. PubMed ID: 17034139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Erythromycine].
    MONGIN M
    Mars Med; 1955; 92(6):368-72. PubMed ID: 14393121
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinic intervention study on urogenital mycoplasma infection of pregnant women].
    Ye Y; Tu S; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Aug; 22(4):293-5. PubMed ID: 11718071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical study and determination of blood and salivary level of erythromycin ethyl-succinate].
    Berthelot ; Biou ; Chabbert ; Vitenberg
    Inf Dent; 1968 Oct; 50(41):3627-8. PubMed ID: 5245648
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical trial of erythromycin stearate suspension.
    Smith DD
    Med J Aust; 1971 May; 1(18):982. PubMed ID: 5577264
    [No Abstract]   [Full Text] [Related]  

  • 58. Correlation of in vivo bioavailability of erythromycin stearate tablets with in vitro tests.
    Stavchansky S; Doluisio JT; Martin A; Martin C; Cabana B; Dighe S; Loper A
    J Pharm Sci; 1980 Nov; 69(11):1307-10. PubMed ID: 7452460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates?
    Patole SK; Almonte R; Kadalraja R; Tuladhar R; Muller R; Whitehall JS
    Int J Clin Pract; 2000 Oct; 54(8):504-8. PubMed ID: 11198727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of Abboticine in stomatologic hospital practice. (Study and report on 26 cases)].
    Freidel C; Deidier C
    Ann Odontostomatol (Lyon); 1968; 25(4):149-54. PubMed ID: 5683852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.